RNAC
Cartesian Therapeutics Inc.
$7.24
+$0.09(+1.26%)
42
Overall
40
Value
45
Tech
--
Quality
Market Cap
$198.15M
Volume
127.39K
52W Range
$5.98 - $26.50
Target Price
$36.43
Key Metrics Overview
| Market Cap | $198.15M | P/E Ratio | N/A |
| 52W High | $26.50 | 52W Low | $5.98 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -173.1% | 52W Position | 6.1% |
| Overall Score | 42 | Value Score | 40 |
| Quality Score | -- | Technical Score | 45 |
Growth Analysis
| EPS Current Est | $-2.47 | EPS Next Est | $-3.51 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $7.24 | +1.3% | 127.39K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW